196 related articles for article (PubMed ID: 20228595)
21. [Primary hyperparathyroidism. An alternative to the surgery].
Díaz Guardiola P; Vega Piñero B; Alameda Hernando C; Pavón de Paz I; Iglesias Bolaños P; Guijarro de Armas G
Endocrinol Nutr; 2009 Mar; 56(3):132-5. PubMed ID: 19627726
[TBL] [Abstract][Full Text] [Related]
22. Cinacalcet hydrochloride relieves hypercalcemia in Japanese patients with parathyroid cancer and intractable primary hyperparathyroidism.
Takeuchi Y; Takahashi S; Miura D; Katagiri M; Nakashima N; Ohishi H; Shimazaki R; Tominaga Y
J Bone Miner Metab; 2017 Nov; 35(6):616-622. PubMed ID: 27873072
[TBL] [Abstract][Full Text] [Related]
23. Cinacalcet in the treatment of intractable hypercalcemia following two neck exploration surgeries for primary hyperparathyroidism.
Padmanabhan H
South Med J; 2010 Mar; 103(3):272-5. PubMed ID: 20134376
[TBL] [Abstract][Full Text] [Related]
24. Primary hyperparathyroidism during pregnancy.
Dochez V; Ducarme G
Arch Gynecol Obstet; 2015 Feb; 291(2):259-63. PubMed ID: 25367603
[TBL] [Abstract][Full Text] [Related]
25. Management of skeletal health in patients with asymptomatic primary hyperparathyroidism.
Lewiecki EM
J Clin Densitom; 2010; 13(4):324-34. PubMed ID: 21029971
[TBL] [Abstract][Full Text] [Related]
26. Cinacalcet normalizes serum calcium in a double-blind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgery.
Khan A; Bilezikian J; Bone H; Gurevich A; Lakatos P; Misiorowski W; Rozhinskaya L; Trotman ML; Tóth M
Eur J Endocrinol; 2015 May; 172(5):527-35. PubMed ID: 25637076
[TBL] [Abstract][Full Text] [Related]
27. [Medical treatment of patients with primary hyperparathyroidism].
Vestergaard P; Mosekilde L
Ugeskr Laeger; 2009 Aug; 171(33):2284-7. PubMed ID: 19732508
[TBL] [Abstract][Full Text] [Related]
28. [Nephrolithiasis associated with normocalcemic or hypercalcemic primary hyperparathyroidism: focus on calciomimetics].
Brardi S; Ponchietti R; Duranti E
G Ital Nefrol; 2016; 33(6):. PubMed ID: 28134399
[TBL] [Abstract][Full Text] [Related]
29. Cinacalcet HCl suppresses Cyclin D1 oncogene-derived parathyroid cell proliferation in a murine model for primary hyperparathyroidism.
Imanishi Y; Kawata T; Kenko T; Wada M; Nagano N; Miki T; Arnold A; Inaba M
Calcif Tissue Int; 2011 Jul; 89(1):29-35. PubMed ID: 21541686
[TBL] [Abstract][Full Text] [Related]
30. Cinacalcet efficacy in patients with moderately severe primary hyperparathyroidism according to the European Medicine Agency prescription labeling.
Cetani F; Saponaro F; Banti C; Cianferotti L; Vignali E; Chiavistelli S; Viccica G; Pinchera A; Marcocci C
J Endocrinol Invest; 2012 Jul; 35(7):655-60. PubMed ID: 21971564
[TBL] [Abstract][Full Text] [Related]
31. [Long-term combined treatment with cinacalcet and bisphosphonates in persistent primary hyperparathyroidism after surgery].
Iglesias P; Castro JC; Abreu C; Díez JJ
Med Clin (Barc); 2012 May; 138(15):685-6. PubMed ID: 22197597
[No Abstract] [Full Text] [Related]
32. Multiple myeloma presenting with recurrent hypercalcemia in a patient with a history of primary hyperparathyroidism: report of case and review of literature.
Khandwala HM; Boctor MA
Endocr Pract; 2004; 10(4):345-7. PubMed ID: 15760779
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness and safety of cinacalcet for primary hyperparathyroidism: a single center experience.
Manaka K; Sato J; Kinoshita Y; Ito N; Fujita M; Iiri T; Nangaku M; Makita N
Endocr J; 2019 Aug; 66(8):683-689. PubMed ID: 31092749
[TBL] [Abstract][Full Text] [Related]
34. The diagnosis and management of asymptomatic primary hyperparathyroidism.
Silverberg SJ; Bilezikian JP
Nat Clin Pract Endocrinol Metab; 2006 Sep; 2(9):494-503. PubMed ID: 16957763
[TBL] [Abstract][Full Text] [Related]
35. [Hypercalcemia (with treatment)].
Prié D
Rev Prat; 2006 Oct; 56(16):1827-33. PubMed ID: 17315511
[No Abstract] [Full Text] [Related]
36. Intravenous pamidronate for hypercalcemia of primary hyperparathyroidism.
Tal A; Graves L
South Med J; 1996 Jun; 89(6):637-40. PubMed ID: 8638211
[TBL] [Abstract][Full Text] [Related]
37. Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism.
Marcocci C; Chanson P; Shoback D; Bilezikian J; Fernandez-Cruz L; Orgiazzi J; Henzen C; Cheng S; Sterling LR; Lu J; Peacock M
J Clin Endocrinol Metab; 2009 Aug; 94(8):2766-72. PubMed ID: 19470620
[TBL] [Abstract][Full Text] [Related]
38. Different treatment strategies in primary hyperparathyroidism during pregnancy.
Eremkina A; Bibik E; Mirnaya S; Krupinova J; Gorbacheva A; Dobreva E; Mokrysheva N
Endocrine; 2022 Sep; 77(3):556-560. PubMed ID: 35821184
[TBL] [Abstract][Full Text] [Related]
39. MEN1-related hyperparathyroidism: response to cinacalcet and its relationship with the calcium-sensing receptor gene variant Arg990Gly.
Filopanti M; Verga U; Ermetici F; Olgiati L; Eller-Vainicher C; Corbetta S; Persani L; Beck-Peccoz P; Spada A
Eur J Endocrinol; 2012 Aug; 167(2):157-64. PubMed ID: 22577108
[TBL] [Abstract][Full Text] [Related]
40. Concomitant Primary Hyperparathyroidism in Patients with Multiple Myeloma: A Possible Link?
Notarfranchi L; Marchica V; Dalla Palma B; Pelagatti L; Burroughs-Garcia J; Pedrazzoni M; Ruffini L; Cetani F; Marcocci C; Giuliani N
Acta Haematol; 2021; 144(3):302-307. PubMed ID: 32906140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
